Poor insight in schizophrenia is prevalent across cultures and phases of illness. In this
review, we examine the recent research on the relationship of insight with behavior, mood …

Comorbid major depressive disorder (MDD) in schizophrenia (SZ; SZ-MDD) has been
identified as a major prognostic factor. However, the prevalence and associated factors of …

Adherence to antipsychotic medication is critical for the treatment of patients with
schizophrenia. Impaired insight into illness is one of the principal drivers of medication …

Medication non adherence in schizophrenia is a major cause of relapse and hospitalization
and remains for clinicians an important challenge. This study investigates the associations …

Introduction Schizophrenia is recognized for its severe impact on both patients and
caregivers. In a 12-month follow-up randomized clinical trial, we aimed to measure the …

The integrated model of insight in schizophrenia suggests that poor insight is the result of
multiple factors which compromise persons' abilities to integrate streams of information into …

De-institutionalization of mental health patients has evolved, over nearly 3 generations now,
to a status quo of mental health patients experiencing myriad contacts with first-responders …

The introduction of chlorpromazine and the work that ensued provided the foundation to
reposition schizophrenia as a biological illness. The present paper follows the evolution of …

Background Poor adherence and negative attitudes to treatment are common clinical
problems when treating psychotic disorders. This study investigated how schizophrenia core …

The aim of the present study was to explore the characteristics of psychotropic treatment and
of psychosocial functioning associated with self-reported medication adherence in persons …